-
21.
公开(公告)号:ES2532967T3
公开(公告)日:2015-04-06
申请号:ES11178126
申请日:2005-03-11
Applicant: VERTEX PHARMA
Inventor: TANOURY GERALD J , CHEN MINZHANG , JONES ANDREW D , NYCE PHILIP L , TRUDEAU MARTIN , GUERIN DAVID J , SNOONIAN JOHN R
IPC: C07D405/12 , C07B43/04 , C07B57/00
Abstract: Un proceso de preparación de un compuesto de beta-amidocarbonilo de fórmula XXX:**Fórmula** que comprende las etapas de: a) hacer reaccionar un compuesto de fórmula XII:**Fórmula** con un compuesto de fórmula XIII:**Fórmula** en presencia de un catalizador de paladio, un ligando de paladio, una base y un disolvente que incluye opcionalmente un catalizador de transferencia de fase y que incluye opcionalmente agua, para producir un compuesto de fórmula XXXI:**Fórmula** en la que: X es un grupo saliente; cada Ra es H, un alquilo opcionalmente sustituido, un arilo opcionalmente sustituido, -CN, -C(O)-Oalquilo o halógeno; cada R2 es independientemente un grupo alifático opcionalmente sustituido, un grupo heterocíclico opcionalmente sustituido o un grupo arilo opcionalmente sustituido; cada R4 es independientemente un alifático opcionalmente sustituido, un heterociclo opcionalmente sustituido, un arilo opcionalmente sustituido, o R2 y R4, junto con los grupos a los que están unidos, forman un anillo heterocíclico de 5 a 8 miembros opcionalmente sustituido; y cada R3 es un resto orgánico.
-
22.
公开(公告)号:PT2399916E
公开(公告)日:2015-03-17
申请号:PT11178128
申请日:2005-03-11
Applicant: VERTEX PHARMA
Inventor: NYCE PHILIP L , CHEN MINZHANG , TANOURY GERALD J , JONES ANDREW D , TRUDEAU MARTIN , GUERIN DAVID J , SNOONIAN JOHN R
IPC: C07D405/12 , C07B43/04 , C07B57/00
-
公开(公告)号:AU2014224107A1
公开(公告)日:2014-10-02
申请号:AU2014224107
申请日:2014-09-12
Applicant: VERTEX PHARMA
Inventor: JONES ANDREW D , GUERIN DAVID J , TANOURY GERALD J , NYCE PHILIP L , TRUDEAU MARTIN , CHEN MINZHANG , SNOONIAN JOHN R
IPC: C07B43/04 , C07B57/00 , C07D405/12
Abstract: PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF ASPARTIC ACETAL CASPASE INHIBITORS Abstract The invention relates to processes such as that shown in the scheme and compounds 5 useful for producing modified aspartic acid derivatives, such as aspartic acid aldehyde moieties. Aspartic acid derivatives are useful for preparing caspase inhibitors and/or prodrugs thereof.
-
公开(公告)号:PL2194043T3
公开(公告)日:2014-07-31
申请号:PL10155058
申请日:2006-08-18
Applicant: VERTEX PHARMA
Inventor: TANOURY GERALD J , CHEN MINZHANG , COCHRAN JOHN E
IPC: C07D209/52 , A61K31/403 , C07D471/08
-
公开(公告)号:SG2014013338A
公开(公告)日:2014-06-27
申请号:SG2014013338
申请日:2006-08-18
Applicant: VERTEX PHARMA
Inventor: TANOURY GERALD J , CHEN MINZHANG , COCHRAN JOHN E
Abstract: The invention relates to compounds and processes useful for the preparation of protease inhibitors, particularly serine protease inhibitors. The protease inhibitors are useful for treatment of HCV infections.
-
公开(公告)号:PL1934179T4
公开(公告)日:2014-03-31
申请号:PL06813568
申请日:2006-08-18
Applicant: VERTEX PHARMA
Inventor: TANOURY GERALD J , CHEN MINZHANG , COCHRAN JOHN E
IPC: C07D209/52
-
公开(公告)号:NZ595817A
公开(公告)日:2014-03-28
申请号:NZ59581710
申请日:2010-04-27
Applicant: VERTEX PHARMA
Inventor: LOOKER ADAM , CHEN MINZHANG , JURKAUSKAS VALDAS , TANOURY GERALD J , COCHRAN JOHN E
IPC: C07D209/52 , A61K31/403 , C07D471/08 , C07K7/02
Abstract: 595817 Disclosed herein are processes for preparing a mixture of cis- and trans-octctahydropenta[c]pyrrole-1-carboxylic acids of formula 7, wherein R’ substituents are described in the specification, comprising carboxylation of an azabicyclooctane of formula 6, and equilibrating in the presence of a suitable base wherein the trans-/cis-ratio is greater than 80 to 20, or 90 to 10 or 98 to 2. Also disclosed herein are processes for preparing a compound of formula 4, comprising providing a compound of Formula 7 forming a salt with an optically active amine; crystallizing the salt; esterifying the acid provided in step iii); removing the N-alkoxycarbonyl group to produce (1S,3aR,6aS)-t-butyl-octahydrocyclopenta[c]pyrrole-1-carboxylate, t-butyl ester; reacting the bicyclic aminoester of step v) with a protected amino acid of Formula 26, wherein Z is an amine protecting group, in the presence of a coupling reagent, to produce an amide-ester of Formula 27; removing the protecting group Z from the amide-ester of step vi) to produce the amino compound of Formula 28; reacting the amino compound of Formula 28 with a protected amino acid of Formula 29in the presence of a coupling reagent to produce a tripeptide of Formula 30; removing the protecting group Z in the tripeptide of Formula 30 to produce a free amino-tripeptide of Formula 31; reacting the amino-tripeptide of Formula 31 with pyrazine-2-carboxylic acid in the presence of a coupling reagent to produce an amide-tripeptide ester of Formula 33; hydrolyzing the ester of the amide-tripeptide ester of Formula 33 to produce an amide-tripeptide acid of Formula 34; reacting the amide-tripeptide acid of Formula 34 with an aminohydroxy-amide of Formula 18in the presence of a coupling reagent to produce a hydroxy-tetrapeptide of Formula 35; and oxidizing the hydroxy group of Formula 35 to produce the compound of Formula 4.
-
公开(公告)号:ES2449268T3
公开(公告)日:2014-03-19
申请号:ES10155058
申请日:2006-08-18
Applicant: VERTEX PHARMA
Inventor: TANOURY GERALD J , CHEN MINZHANG , COCHRAN JOHN E
IPC: C07D209/52 , A61K31/403 , C07D471/08
Abstract: Proceso de purificación del compuesto de Fórmula 4, que comprende:**Fórmula** a) disolver el compuesto de Fórmula 4 en un disolvente orgánico para obtener una solución del compuesto deFórmula 4, b) añadir un ácido a la solución del compuesto de Fórmula 4, y c) concentrar la solución del compuesto de Fórmula 4 para obtener el compuesto en una forma sólida.
-
公开(公告)号:MX2012012204A
公开(公告)日:2012-12-05
申请号:MX2012012204
申请日:2011-04-21
Applicant: VERTEX PHARMA
Inventor: TANOURY GERALD J , JUNG YOUNG CHUN , LEE ELAINE CHUNGMIN , HARRISON CRISTIAN , LITTLER BENJAMIN JOSEPH , ROSE PETER JAMISON , HUGHES ROBERT MICHAEL , SIESEL DAVID ANDREW , BELMONT DANIEL T
IPC: C07D209/12 , C07D317/60 , C07D405/12
Abstract: La presente invención presenta procesos para preparar compuestos, tal como (R)-1-(2, 2-difluorobenzo-[d] [1,3] dioxol-5-il)-N-(1-(2, 3-dihidroxipropil)-6-fluoro-2-(1-hidroxi-2-metilpropan-2-il)-1H-i ndol-5-il) ciciopropano-carboxamida (Compuesto 1), útil para tratar enfermedades mediadas por CFTR tal como fibrosis quística.
-
公开(公告)号:AU2012201242A1
公开(公告)日:2012-03-22
申请号:AU2012201242
申请日:2012-03-01
Applicant: VERTEX PHARMA
Inventor: JONES ANDREW D , GUERIN DAVID J , TANOURY GERALD J , NYCE PHILIP L , TRUDEAU MARTIN , CHEN MINZHANG , SNOONIAN JOHN R
IPC: C07B43/04 , C07B57/00 , C07D405/12
Abstract: Processes and intermediates for the preparation of aspartic acetal caspase inhibitors Abstract The invention relates to processes such as that shown in the scheme and compounds useful for producing modified aspartic acid derivatives, such as aspartic acid aldehyde s moieties. Aspartic acid derivatives are useful for preparing caspase inhibitors and/or prodrugs thereof.
-
-
-
-
-
-
-
-
-